NCT01527695 - PET Study in Parkinson's Disease Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions

Parkinson's Disease

Interventions

DRUG

ER tablet 25 mg AZD3241

2 tablets twice daily for Day 1

DRUG

ER tablet 100 mg AZD3241

1-6 tablets twice daily from Day 2 until Day 56±3 days

DRUG

Placebo for AZD3241 25 mg

2 tablets twice daily for Day 1

DRUG

Placebo for AZD3241 100 mg

1-6 tablets twice daily from Day 2 until Day 56±3 days

Trial Locations (3)

Reserach Site, Stockholm

Research Site, Uppsala

Research Site, Vällingby